CBD, Chronic Pain Management, and Opioid Reduction: Mechanisms and Efficacy

This podcast episode, hosted by Dr. Donnelly Snipes, delves into the significant impact of chronic non-cancer pain, affecting 50 to 116 million Americans, and its pervasive links to insomnia, depression, increased inflammation, and reduced immunity. The discussion highlights the diverse etiologies of pain, ranging from systemic inflammation caused by infections or neurotransmitter imbalances (specifically low serotonin) to neurological dysfunctions like nerve pain and phantom limb sensations. Critically, the episode addresses the current reliance on opioids for chronic pain management, acknowledging their numerous side effects and the urgent need for safer, more effective alternatives.

The core of the presentation focuses on cannabidiol (CBD) as a promising alternative. Dr. Snipes explains CBD's multifaceted mechanisms, including its ability to reduce inflammatory responses, bind to serotonin receptors, and modulate the endogenous opioid system, thereby enhancing the body's natural pain-relieving capabilities. Furthermore, CBD activates T regulatory cells, which play a vital role in preventing autoimmune attacks, a common underlying factor in many inflammatory pain conditions. The episode clarifies that CBD's interaction with the body's natural opioid receptors does not induce a psychoactive 'high,' distinguishing it from THC.

Empirical evidence supporting CBD's efficacy is presented, including a study of 131 chronic pain patients on long-term opioids, where 53% successfully reduced or eliminated their opioid use, and 94% reported improved quality of life within eight weeks. A crucial safety warning is issued: CBD is a cytochrome p450 inhibitor, meaning co-administration with opioids can dangerously elevate opioid blood levels, necessitating strict medical supervision to prevent life-threatening respiratory depression. The podcast also contrasts CBD's safety profile with NSAIDs (e.g., ibuprofen), noting that CBD does not inhibit COX-1 or COX-2 enzymes, thus avoiding the severe gastrointestinal, cardiovascular, and stroke risks associated with NSAIDs.

Specific applications of CBD are explored, demonstrating its effectiveness in reducing postoperative pain, osteoarthritis pain, and significantly decreasing fibromyalgia pain by over 30% in a placebo-controlled study. While CBD may not always significantly reduce objective pain measures in generalized chronic pain, it consistently improves patient-reported quality of life and sleep. The episode also highlights the benefits of transdermal CBD application for peripheral neuropathy, such as in diabetic patients, alleviating burning and tingling sensations. Dr. Snipes concludes by emphasizing that much of the current research is still in its early stages, often conducted on animals or with CBD/THC combinations, underscoring the need for more human-specific studies on CBD alone for conditions like anxiety, depression, and chronic pain.

pain affects 50 to 116 million americans

chronic pain is the number one cause of insomnia which is linked to depression increased inflammation and reduced immunity

studies often show that cbd's effects are mediated by the serotonin receptors and alterations in the endogenous opioid system

cannabidiol or cbd is a cannabinoid that binds to mu and delta opioid receptors

53 of them were able to reduce or eliminate their use of opioids and 94 reported quality of life improvements within eight weeks after beginning to take cbd extract

cbd is an inhibitor of cytochrome p450 so when you take cbd and opioids at the same time it increases the levels of opioids in your blood and it can be life-threatening

the nice thing about cbd is that in it doesn't inhibit the cox-1 or cox-2 enzymes so it doesn't have any of those side effects even at pharmacologically relevant doses

in patients with fibromyalgia in one study cbd treatment decreased pain by more than 30 percent which was significantly greater than what the patients who were on placebo experienced

transdermal application or skin-based application of cbd oil can achieve significant improvement in pain and other disturbing sensations in patients with peripheral neuropathy

a lot of the research has been done on mice not on humans with the exception of those few studies that i cited